BIAMONTE, FLAVIA
 Distribuzione geografica
Continente #
NA - Nord America 809
EU - Europa 768
AS - Asia 120
OC - Oceania 4
AF - Africa 2
Totale 1.703
Nazione #
US - Stati Uniti d'America 806
PL - Polonia 404
RU - Federazione Russa 135
IT - Italia 107
IE - Irlanda 45
CN - Cina 37
SE - Svezia 34
SG - Singapore 30
HK - Hong Kong 25
FI - Finlandia 14
DE - Germania 10
IN - India 9
GB - Regno Unito 7
CH - Svizzera 6
VN - Vietnam 6
AU - Australia 4
AE - Emirati Arabi Uniti 3
CA - Canada 3
ID - Indonesia 3
JO - Giordania 3
TR - Turchia 3
BE - Belgio 2
CI - Costa d'Avorio 2
AZ - Azerbaigian 1
EE - Estonia 1
FR - Francia 1
NL - Olanda 1
UA - Ucraina 1
Totale 1.703
Città #
Warsaw 404
Santa Clara 289
Fairfield 87
Ashburn 45
Dublin 44
Chandler 42
Catanzaro 40
Seattle 36
Woodbridge 32
Cambridge 31
Houston 28
Singapore 27
Ann Arbor 23
Wilmington 23
Hong Kong 21
Beijing 20
Lawrence 18
Altamura 17
Princeton 11
Buffalo 10
Boston 9
Shanghai 8
Florence 7
Bern 6
Dong Ket 6
Mumbai 6
Boardman 5
Jacksonville 5
Bremen 4
Cagliari 4
Helsinki 4
Hillsboro 4
Melbourne 4
San Diego 4
Abu Dhabi 3
Dearborn 3
Guidonia Montecelio 3
Jakarta 3
Medford 3
Paola 3
Pune 3
Reggio Calabria 3
Rome 3
Abidjan 2
Bisignano 2
Brussels 2
Catania 2
Guangzhou 2
Milan 2
Nanjing 2
New York 2
Red Deer 2
Redwood City 2
Salerno 2
Scandale 2
Andover 1
Aprilia 1
Baku 1
Bologna 1
Bracciano 1
Cantagallo 1
Corato 1
Eschweiler 1
Fuzhou 1
Greystones 1
Izmir 1
Kent 1
Kilburn 1
Laurel 1
Livorno 1
Moscow 1
Munich 1
Nanchang 1
Newark 1
Norwalk 1
Old Bridge 1
Phoenix 1
Rotterdam 1
Shaoxing 1
Tallinn 1
Torino 1
Toronto 1
Totale 1.402
Nome #
MUTATIONS AND EPIGENETICS IN MYELOPROLIFERATIVE NEOPLASMS 317
Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosis. 277
Characterisation and discovery of novel miRNAs andmoRNAs in JAK2V617F mutated SET2 cells 223
Mutations and prognosis in primary myelofibrosis. 153
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms. 140
Epigenetics and mutations in chronic myeloproliferative neoplasms. 133
Mutational analysis of BCORL1 in the leukemic transformation of chronic myeloproliferative neoplasms. 133
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients. 124
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis 123
The ERCC2 Gln/Gln polymorphism at codon 751 is not associated with leukaemic transformation in primary myelofibrosis. 96
Totale 1.719
Categoria #
all - tutte 3.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.808


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020148 0 0 0 0 0 0 34 31 23 28 29 3
2020/2021143 16 17 4 13 8 19 10 11 12 19 6 8
2021/202282 1 8 7 5 3 0 3 8 1 4 17 25
2022/2023261 17 41 9 15 20 37 32 20 21 38 4 7
2023/202462 6 9 10 0 5 9 3 13 0 3 2 2
2024/2025525 11 49 41 70 209 143 2 0 0 0 0 0
Totale 1.719